Your browser doesn't support javascript.
loading
Disruption of gender-affirming health care, and COVID-19 illness, testing, and vaccination among trans Australians during the pandemic: a cross-sectional survey.
Zwickl, Sav; Ruggles, Tomi; Wong, Alex Fq; Ginger, Ariel; Angus, Lachlan M; Eshin, Kalen; Cook, Teddy; Cheung, Ada S.
Afiliação
  • Zwickl S; The University of Melbourne, Melbourne, VIC.
  • Ruggles T; The University of Melbourne, Melbourne, VIC.
  • Wong AF; The University of Melbourne, Melbourne, VIC.
  • Ginger A; The University of Melbourne, Melbourne, VIC.
  • Angus LM; The University of Melbourne, Melbourne, VIC.
  • Eshin K; Austin Health, Melbourne, VIC.
  • Cook T; La Trobe University, Melbourne, VIC.
  • Cheung AS; ACON, Sydney, NSW.
Med J Aust ; 220(1): 23-28, 2024 01 15.
Article em En | MEDLINE | ID: mdl-37994182
ABSTRACT

OBJECTIVES:

To assess rates of disruption of gender-affirming health care, of coronavirus disease 2019 (COVID-19) illness, testing, and vaccination, and of discrimination in health care among Australian trans people during the COVID-19 pandemic. DESIGN,

SETTING:

Online cross-sectional survey (1-31 May 2022); respondents were participants recruited by snowball sampling for TRANSform, an Australian longitudinal survey-based trans health study, 1 May - 30 June 2020.

PARTICIPANTS:

People aged 16 years or older, currently living in Australia, and with a gender different to their sex recorded at birth. MAIN OUTCOME

MEASURES:

Proportions of respondents who reported disruptions to gender-affirming health care, COVID-19 illness, testing, and vaccination, and positive and negative experiences during health care.

RESULTS:

Of 875 people invited, 516 provided valid survey responses (59%). Their median age was 33 years (interquartile range, 26-45 years); 193 identified as women or trans women (37%), 185 as men or trans men (36%), and 138 as non-binary (27%). Of 448 respondents receiving gender-affirming hormone therapy, 230 (49%) reported disruptions to treatment during the pandemic; booked gender-affirming surgery had been cancelled or postponed for 37 of 85 respondents (44%). Trans-related discrimination during health care was reported by a larger proportion of participants than in a pre-pandemic survey (56% v 26%). COVID-19 was reported by 132 respondents (26%), of whom 49 reported health consequences three months or more after the acute illness (37%; estimated Australian rate 5-10%). Three or more COVID-19 vaccine doses were reported by 448 participants (87%; Australian adult rate 70%).

CONCLUSIONS:

High rates of COVID-19 vaccination among the trans people we surveyed may reflect the effectiveness of LGBTIQA+ community-controlled organisation vaccination programs and targeted health promotion. Training health care professionals in inclusive services for trans people could improve access to appropriate health care and reduce discrimination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / COVID-19 / População Australasiana / Assistência à Saúde Afirmativa de Gênero Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Med J Aust Ano de publicação: 2024 Tipo de documento: Article País de publicação: AU / AUSTRALIA / AUSTRÁLIA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / COVID-19 / População Australasiana / Assistência à Saúde Afirmativa de Gênero Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Med J Aust Ano de publicação: 2024 Tipo de documento: Article País de publicação: AU / AUSTRALIA / AUSTRÁLIA